全文获取类型
收费全文 | 263970篇 |
免费 | 22202篇 |
国内免费 | 8509篇 |
专业分类
耳鼻咽喉 | 3394篇 |
儿科学 | 2814篇 |
妇产科学 | 4667篇 |
基础医学 | 32865篇 |
口腔科学 | 6564篇 |
临床医学 | 18484篇 |
内科学 | 33754篇 |
皮肤病学 | 4098篇 |
神经病学 | 11996篇 |
特种医学 | 10500篇 |
外国民族医学 | 126篇 |
外科学 | 28310篇 |
综合类 | 39466篇 |
现状与发展 | 44篇 |
一般理论 | 8篇 |
预防医学 | 16275篇 |
眼科学 | 2584篇 |
药学 | 29414篇 |
67篇 | |
中国医学 | 13504篇 |
肿瘤学 | 35747篇 |
出版年
2024年 | 182篇 |
2023年 | 3374篇 |
2022年 | 4881篇 |
2021年 | 9882篇 |
2020年 | 8973篇 |
2019年 | 8837篇 |
2018年 | 8776篇 |
2017年 | 9681篇 |
2016年 | 10093篇 |
2015年 | 10231篇 |
2014年 | 12903篇 |
2013年 | 16243篇 |
2012年 | 14299篇 |
2011年 | 16634篇 |
2010年 | 11482篇 |
2009年 | 11579篇 |
2008年 | 13222篇 |
2007年 | 14483篇 |
2006年 | 13666篇 |
2005年 | 12566篇 |
2004年 | 10433篇 |
2003年 | 9301篇 |
2002年 | 7489篇 |
2001年 | 6961篇 |
2000年 | 5837篇 |
1999年 | 4763篇 |
1998年 | 3684篇 |
1997年 | 3597篇 |
1996年 | 3257篇 |
1995年 | 3065篇 |
1994年 | 2921篇 |
1993年 | 2311篇 |
1992年 | 2123篇 |
1991年 | 1942篇 |
1990年 | 1663篇 |
1989年 | 1389篇 |
1988年 | 1330篇 |
1987年 | 1171篇 |
1986年 | 1058篇 |
1985年 | 1457篇 |
1984年 | 1171篇 |
1983年 | 878篇 |
1982年 | 916篇 |
1981年 | 757篇 |
1980年 | 726篇 |
1979年 | 584篇 |
1978年 | 367篇 |
1977年 | 310篇 |
1976年 | 287篇 |
1975年 | 198篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
《介入医学杂志(英文)》2021,4(4):159-171
Pancreatic cancer has become a major disease affecting people's health because of its insidiousness, rapid progression and poor prognosis. Based on the practical needs of clinical work, combined with domestic multi-center research and experience, this guideline provides constructive suggestions for the interventional treatment of pancreatic cancer. 相似文献
102.
M. Xiao H. Song Y. You M. Liu X. Yang Y. Wang 《International journal of oral and maxillofacial surgery》2021,50(4):437-443
Parotid lymph node (PLN) metastasis greatly worsens the prognosis of patients with oral squamous cell carcinoma (OSCC) and poses a great challenge for further treatment of OSCC. The clinicopathological characteristics and treatment strategies for PLN metastasis from OSCC need to be comprehensively elucidated. A retrospective review of OSCC patients who experienced postoperative PLN metastasis in our department between 2000 and 2018 was performed in this study. A total of 47 OSCC patients with postoperative PLN metastasis were identified. PLN with metastasis were divided into three groups based on the location: parotid tail (PLN-t), superficial lobe (PLN-sl), and deep lobe (PLN-dl). Most of the patients experienced PLN metastasis within less than 12 months after the primary surgery for OSCC. Comparatively, patients with PLN-sl metastasis were more prone to have infiltration of the facial nerve. The tongue and buccal mucosa were the most frequent primary sites associated with PLN metastasis from OSCC. PLNs in the parotid tail were most commonly affected by the metastasized OSCC. Consequently, we recommend a series of strategies for the prevention and treatment of PLN metastasis for OSCC patients. In conclusion, PLNs should not be overlooked during preoperative evaluation and postoperative follow-up examinations for OSCC patients. 相似文献
103.
A. Thomas S. Manchella K. Koo A. Tiong A. Nastri D. Wiesenfeld 《International journal of oral and maxillofacial surgery》2021,50(5):585-590
The contemporary literature is discordant regarding the role of delayed diagnosis in the prognosis of patients with oral cancer. This study examined data on a previously reported cohort of 101 patients with oral squamous cell carcinoma diagnosed at a single institution between 2008 and 2010. The time interval between symptom onset and initial histological diagnosis (diagnostic delay) was recorded for each patient, as were demographic data and cancer features such as T stage, nodal status, and smoking status. The mean follow-up period was 4 years 10 months. The mean diagnostic delay was 4 months, mean overall survival was 5 years 6 months, and mean disease-specific survival was 4 years 9 months. No significant correlation was found between diagnostic delay and overall survival, disease-specific survival, or recurrence rates. Patients with node-positive disease were more likely to be diagnosed earlier, whereas women and non-smokers were more likely to have a delayed diagnosis. Inherent tumour biology is likely an important prognostic factor separate to diagnostic delay. Public education efforts should focus on symptom recognition and encourage early presentation for investigation of oral lesions, particularly for females and non-smokers, so that more aggressive tumours can be treated sooner to give the best chance at survival. 相似文献
104.
《International journal of oral and maxillofacial surgery》2021,50(11):1422-1428
It is clinically challenging to identify oral leukoplakias that have a high risk of undergoing malignant transformation. The aim of this retrospective study was to elucidate the associations between malignant transformation of oral leukoplakias and various clinicopathologic factors. Patients with a diagnosis of clinical oral leukoplakia, verified through histopathologic examination and with access to digital images of the lesion, were retrospectively included for the period 2003–2013. Using the clinical images, all lesions were re-evaluated regarding diagnosis and clinical subtype. Of the 234 included patients, with a median follow-up of 9 years, 27 (11.5%) developed oral squamous cell carcinoma. Among the clinicopathologic factors investigated, non-homogeneous oral leukoplakia (OL), OL with dysplasia, and OL localized to the tongue showed statistically significant increased rates of malignant transformation in the multivariate Cox regression analysis. Non-homogeneous OL showed a 15.2-times higher transformation rate than homogenous OL (P < 0.001). Dysplastic leukoplakias developed into carcinomas 2.4-times more often than did non-dysplastic leukoplakias (P = 0.048). OL located on the tongue showed a 2.8-times higher malignant transformation rate than OLs at other oral locations (P = 0.018), when other locations were combined into one group. Non-homogeneous OL, OL with dysplasia, and OL localized to the tongue have higher transformation rates. 相似文献
105.
106.
107.
108.
笔者根据现代临床子宫内膜的病理演变过程结合中医“异病同治”理念,提出“子宫内膜功能亢进性疾病”概念,涵盖5种常见的子宫内膜疾病:无排卵性异常子宫出血(Abnormal Uterine Bleeding Ovulatory dysfunction,AUB-O),子宫内膜息肉(Endometrial Polyp,EP),子宫内膜异位症(Endometriosis,EMs),子宫腺肌病(Adenomyosis,AM),子宫内膜癌(Endometrial Carcinoma,EC)。基于文献的汇总,分析得到此类疾病的子宫内膜病理演变与中医病因病机的关联性,为寻找关键通路、创新性治疗此类疾病提供了重要的参考方向,对深化中医妇科学常见疾病的共性病因病机提供了理论依据和探索思路。 相似文献
109.
Saleh A Alqahtani Massimo G Colombo 《World journal of gastrointestinal oncology》2021,13(12):2038-2049
Globally, hepatocellular carcinoma (HCC) is a frequently diagnosed malignancy with rapidly increasing incidence and mortality rates. Unfortunately, many of these patients are diagnosed in the advanced stages when locoregional treatments are not appropriate. Before 2008, no effective drug treatments existed to prolong survival, until the breakthrough multi-tyrosine kinase inhibitor (TKI) sorafenib was developed. It remained the standard treatment option for advanced HCC for 10 years, with a battery of other candidate drugs in clinical trials failing to produce similar efficacy results. In 2018, the REFLECT trial introduced another multi-TKI, lenvatinib, which has non-inferior overall survival compared with sorafenib. Thus, offering patients and their treating physicians two effective treatment options. Recently, immunotherapy-based drugs, such as atezolizumab and bevacizumab, have shown promising results in patients with unresectable HCC. This review summarizes clinical trial and real-world data studies of sorafenib and lenvatinib in patients with unresectable HCC. We offer guidance on the optimal choice between the two treatments and discuss the potential of immunotherapy-based combination; when more data become available, this will likely make the choice between sorafenib and lenvatinib somewhat obsolete. 相似文献
110.
目的比较基因组拷贝数变异测序(CNV-seq)技术和染色体核型分析和在产前胎儿遗传学诊断中的应用价值。方法收集来我院有产前诊断指征进行羊水穿刺的259例孕妇,取材后,送检染色体核型分析和CNV-seq,比较两种方法在产前诊断中的优缺点。结果259例标本中,共诊断异常染色体核型及微缺失微重复23例,总阳性诊断率8.88%(23/259),CNV-seq结果显示,共有22例染色体拷贝数异常(12例三体+9例微缺失微重复+1例三倍体),检出率为8.49%;染色体核型分析结果显示为:17例染色体异常(12例三体+3例结构异常+1例嵌合型+1例三倍体),检出率为6.56%。此外还检出染色体多态7例。结论CNV-seq与染色体核型分析对于染色体非整倍体的检测效力一致,CNV-seq能检测染色体微缺失微重复,染色体核型分析则能诊断出三体具体核型,在怀疑性染色体异常时,建议行两者联合检测。 相似文献